Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Berlin plans six vast COVID-19 vaccination centres handling 4,000 people a day

Thu, 26th Nov 2020 15:32

By Caroline Copley

BERLIN, Nov 26 (Reuters) - Berlin is racing to open six mass
vaccination centres capable of handling up to 4,000 people per
day by mid-December, the project coordinator told Reuters on
Thursday, as the city waits for authorities to approve the first
vaccines.

An empty trade fair hall, two airport terminals, a concert
arena, a velodrome and an ice rink will be turned into six
vaccination centres where it plans to administer up to 900,000
shots against the coronavirus in the first three months.

Albrecht Broemme said plans envisage 3,000 to 4,000 people
per day being ferried through each centre in the same way as
shoppers are guided through IKEA stores in one direction.

"The biggest challenge will be succeeding in getting the
right people at the right time at the right vaccination centre,"
Broemme said on the sidelines of a fire drill at the city's
makeshift COVID-19 hospital in a trade fair hall.

Germany appears to be the furthest ahead of European nations
in its planning for the daunting logistical and administrative
challenge that could be just a few weeks away if the first
vaccines gain approval.

Europe's drug watchdog expects to receive the first
application for conditional marketing approval for a COVID-19
vaccine "in the coming days", it said on Thursday, the latest
step towards making a shot available outside the United States.

Broemme said Berlin is working on the assumption that around
80% of its doses in the first instance will come from Pfizer
/BioNTech with the remaining 20% of the doses
from AstraZeneca.

Health Minister Jens Spahn said Germany has secured around
300 million vaccine doses. Other German states have said
vaccination centres will be ready from mid-December and mobile
teams will inoculate the most vulnerable.

Elsewhere in Europe, preparations appear mixed.

In Spain, the government aims to vaccinate a substantial
part of its population in the first half of 2021 and has opted
to use trucks rather than centres to distribute the shots.

Italy expects to have vaccinated most Italians by next
September and is due to set out detailed plans on Dec. 2. France
has said it could start administering shots as soon as the end
of the year and will unveil its strategy next week.

Britain plans to roll out vaccines using a mixture of
centres and doctors' practices and is aiming to have enough
shots to have some sort of normality after Easter.

In contrast, Hungary and Bulgaria are not expecting to
receive their first shipments until Spring.

Berlin's vaccination centres will be open seven days a week
and on public holidays from 0900 to 1900, Broemme said, with the
aim of completing the first phase within three months. After
that people will get shots at doctors' practices and pharmacies.

Those aged over 75 and healthcare workers are expected to be
first-in-line, the city's health senator said last week.

One challenge will be finding enough staff to operate the
centres, which will need medical professionals, stewards and
security guards. EasyJet has offered some of its
first-aid trained staff, a spokesman said.

Broemme expects each person to spend around one hour in the
centre. People will be monitored for side effects for around 30
minutes after receiving a shot amid strict social-distancing and
hygiene standards.
(Reporting by Caroline Copley
Additional reporting by Alistair Smout and Sarah Young in
London, Emilio Paradi in Milan, Emma Pinedo Gonzalez in Madrid,
Matthias Blamont in Paris, Krisztina Than in Budapest, Tsvetelia
Tsolova in Sofia)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.